The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Fletcher Mark since year 2005.
The trader's CIK number is 1229529.
At the time of this reporting, Fletcher Mark is the President & CEO of Generex Biotechnology Corp .
(stock ticker symbol GNBT).
See this page for all insider trading activities at Generex Biotechnology Corp .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2016-02-09||GNBT||Generex Biotechnology Corp||Option Ex||14,890,033||.00||14,890|
|2014-10-06||GNBT||Generex Biotechnology Corp||Option Ex||470,726||.00||470|
|2011-04-06||GNBT||Generex Biotechnology Corp||Buy||20,000||.24||4,780|
|2009-11-13||GNBT||Generex Biotechnology Corp||Buy||10,000||.49||4,900|
|2009-01-12||GNBT||Generex Biotechnology Corp||Buy||12,359||.32||4,016|
|2008-10-31||GNBT||Generex Biotechnology Corp||Buy||25,000||.38||9,375|
|2008-04-18||GNBT||Generex Biotechnology Corp||Option Ex||250,000||.89||222,500|
|2008-04-18||GNBT||Generex Biotechnology Corp||Sale||228,342||1.15||262,593|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fletcher Mark (President & CEO of Generex Biotechnology Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.